SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ryosuke Saigusa, Yoshihide Asano, Kouki Nakamura, Shunsuke Miura, Yohei Ichimura, Takehiro Takahashi, Tetsuo Toyama, Takashi Taniguchi, Shinji Noda, Naohiko Aozasa, Kaname Akamata, Hayakazu Sumida, Miki Miyazaki, Zenshiro Tamaki, Koichi Yanaba, Yoshihiro Kuwano, Shinichi Sato, Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis, The Journal of Dermatology, 2015, 42, 5
  2. 2
    Richard C. Cabot, Eric S. Rosenberg, Nancy Lee Harris, Jo-Anne O. Shepard, Alice M. Cort, Sally H. Ebeling, Emily K. McDonald, Fredrick Wigley, Robert P. Friday, Jo-Anne O. Shepard, Rosalynn M. Nazarian, Case 8-2015, New England Journal of Medicine, 2015, 372, 11, 1056

    CrossRef

  3. 3
    Case 8-2015: A Man with Multiple Myeloma, Skin Tightness, Arthralgias, and Edema, New England Journal of Medicine, 2015, 372, 25, 2465

    CrossRef

  4. 4
    T. Hua-Huy, A.T. Dinh-Xuan, Cellular and molecular mechanisms in the pathophysiology of systemic sclerosis, Pathologie Biologie, 2015, 63, 2, 61

    CrossRef

  5. 5
    Yasuhito Hamaguchi, Masanari Kodera, Takashi Matsushita, Minoru Hasegawa, Yuki Inaba, Toshikazu Usuda, Masataka Kuwana, Kazuhiko Takehara, Manabu Fujimoto, Clinical and Immunologic Predictors of Scleroderma Renal Crisis in Japanese Systemic Sclerosis Patients With Anti–RNA Polymerase III Autoantibodies, Arthritis & Rheumatology, 2015, 67, 4
  6. 6
    Jasmin Raja, Christopher Paul Denton, Cytokines in the immunopathology of systemic sclerosis, Seminars in Immunopathology, 2015,

    CrossRef

  7. You have free access to this content7
    Sei-ichiro Motegi, Sayaka Toki, Kazuya Yamada, Akihiko Uchiyama, Osamu Ishikawa, Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies, The Journal of Dermatology, 2015, 42, 2
  8. 8
    Ami A. Shah, Laura K. Hummers, Livia Casciola-Rosen, Kala Visvanathan, Antony Rosen, Fredrick M. Wigley, Examination of Autoantibody Status and Clinical Features Associated With Cancer Risk and Cancer-Associated Scleroderma, Arthritis & Rheumatology, 2015, 67, 4
  9. 9
    Benjamin D. Korman, Lindsey A. Criswell, Recent Advances in the Genetics of Systemic Sclerosis: Toward Biological and Clinical Significance, Current Rheumatology Reports, 2015, 17, 3

    CrossRef

  10. 10
    Ami A. Shah, Livia Casciola-Rosen, Antony Rosen, Review: Cancer-Induced Autoimmunity in the Rheumatic Diseases, Arthritis & Rheumatology, 2015, 67, 2
  11. 11
    Edward P. Stern, Christopher P. Denton, The Pathogenesis of Systemic Sclerosis, Rheumatic Disease Clinics of North America, 2015, 41, 3, 367

    CrossRef

  12. 12
    Carlo Chizzolini, Francesco Boin, The role of the acquired immune response in systemic sclerosis, Seminars in Immunopathology, 2015,

    CrossRef

  13. 13
    Pia Moinzadeh, Carmen Fonseca, Martin Hellmich, Ami A Shah, Cecilia Chighizola, Christopher P Denton, Voon H Ong, Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma, Arthritis Research & Therapy, 2014, 16, 1, R53

    CrossRef

  14. 14
    C. G. Joseph, E. Darrah, A. A. Shah, A. D. Skora, L. A. Casciola-Rosen, F. M. Wigley, F. Boin, A. Fava, C. Thoburn, I. Kinde, Y. Jiao, N. Papadopoulos, K. W. Kinzler, B. Vogelstein, A. Rosen, Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer, Science, 2014, 343, 6167, 152

    CrossRef

  15. 15
    M. W. L. Teng, M. J. Smyth, Can Cancer Trigger Autoimmunity?, Science, 2014, 343, 6167, 147

    CrossRef

  16. 16
    Virginia D. Steen, Kidney involvement in systemic sclerosis, La Presse Médicale, 2014, 43, 10, e305

    CrossRef

  17. 17
    Beate Eckes, Pia Moinzadeh, Gerhard Sengle, Nico Hunzelmann, Thomas Krieg, Molecular and cellular basis of scleroderma, Journal of Molecular Medicine, 2014, 92, 9, 913

    CrossRef

  18. 18
    George Stojan, Peter B. Illei, Rex C. Yung, Allan C. Gelber, Raynaud's Phenomenon, Inflammatory Arthritis, and Weight Loss: Pay Attention to the Man Behind the Curtain, Arthritis Care & Research, 2014, 66, 8
  19. 19
    Robyn T. Domsic, Scleroderma, Current Opinion in Rheumatology, 2014, 26, 6, 646

    CrossRef

  20. 20
    Shinji Noda, Yoshihide Asano, Satoshi Nishimura, Takashi Taniguchi, Katsuhito Fujiu, Ichiro Manabe, Kouki Nakamura, Takashi Yamashita, Ryosuke Saigusa, Kaname Akamata, Takehiro Takahashi, Yohei Ichimura, Tetsuo Toyama, Daisuke Tsuruta, Maria Trojanowska, Ryozo Nagai, Shinichi Sato, Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis, Nature Communications, 2014, 5, 5797

    CrossRef

  21. 21
    Sonal Mehra, Jennifer Walker, Karen Patterson, Marvin J. Fritzler, Autoantibodies in systemic sclerosis, Autoimmunity Reviews, 2013, 12, 3, 340

    CrossRef

  22. 22
    Tatiana Nevskaya, Shelly Chandran, Adrienne M. Roos, Christopher R. Pasarikovski, Amie Kron, Cathy Chau, Sindhu R. Johnson, Epidemiology of Cancer in Systemic Sclerosis—Systematic Review and Meta-Analysis of Cancer Incidence, Predictors and Mortality*, Open Journal of Rheumatology and Autoimmune Diseases, 2013, 03, 04, 231

    CrossRef

  23. 23
    Ami A. Shah, Fredrick M. Wigley, My Approach to the Treatment of Scleroderma, Mayo Clinic Proceedings, 2013, 88, 4, 377

    CrossRef

  24. 24
    Lama Azar, Atul Khasnis, Paraneoplastic rheumatologic syndromes, Current Opinion in Rheumatology, 2013, 25, 1, 44

    CrossRef

  25. 25
    Alison Gjidoda, R. William Henry, RNA polymerase III repression by the retinoblastoma tumor suppressor protein, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2013, 1829, 3-4, 385

    CrossRef

  26. 26
    Eliza F. Chakravarty, Kelley's Textbook of Rheumatology, 2013,

    CrossRef

  27. 27
    Eric L. Matteson, Kelley's Textbook of Rheumatology, 2013,

    CrossRef

  28. 28
    C-F Kuo, S-F Luo, K-H Yu, I-J Chou, W-Y Tseng, H-C Chang, Y-F Fang, M-J Chiou, L-C See, Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan, Scandinavian Journal of Rheumatology, 2012, 41, 1, 44

    CrossRef

  29. 29
    Masaru HONMA, Shigetsuna KOMATSU, Satomi IGAWA, Masamoto MURAKAMI, Hajime IIZUKA, Rapidly progressive systemic sclerosis associated with breast carcinoma: Report of a case with anti-RNA polymerase III antibody, The Journal of Dermatology, 2012, 39, 6
  30. 30
    Ami A. Shah, Antony Rosen, Cancer and systemic sclerosis, Current Opinion in Rheumatology, 2011, 23, 6, 530

    CrossRef

  31. 31
    Cecilia Chighizola, Voon H Ong, Christopher P Denton, Cyclophosphamide as disease-modifying therapy for scleroderma: pros and cons, International Journal of Clinical Rheumatology, 2011, 6, 2, 219

    CrossRef

  32. 32
    Mandana Nikpour, Pravin Hissaria, Jillian Byron, Joanne Sahhar, Maree Micallef, William Paspaliaris, Janet Roddy, Peter Nash, Alan Sturgess, Susanna Proudman, Wendy Stevens, Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort, Arthritis Research & Therapy, 2011, 13, 6, R211

    CrossRef

  33. 33
    Judith F. Ashouri, David I. Daikh, Rheumatic Manifestations of Cancer, Rheumatic Disease Clinics of North America, 2011, 37, 4, 489

    CrossRef